News center | Australia

Jul 31, 2025

Philips partnership with Western Australia Health delivers significant patient care and cost improvements through remote monitoring innovation


Sydney, Australia – Royal Perth Hospital’s innovative study into remote continuous vital sign monitoring for scoliosis surgery patients has demonstrated a meaningful shift in post-operative care, made possible through a close collaboration with Philips, a global leader in health technology.

ICU virtual monitoring with eCareManager

The study, published in Anesthesia & Analgesia, evaluates the economic and clinical impact of the “Health in a Virtual Environment” (HIVE) service. Enabled by Philips’ advanced patient monitoring technologies, the HIVE model reduced intensive care unit (ICU) hours by 69% and saved AU$2,682 per patient in overall hospital costs, all without compromising patient safety [1].

This achievement marks a significant milestone in Australia’s journey toward a smarter, more connected health system.

Our partnership with East Metropolitan Health Service reflects our shared vision to reimagine healthcare delivery. By combining cutting-edge remote monitoring solutions with local clinical leadership, we’ve helped create a scalable model of care that improves outcomes, reduces pressure on scarce high acuity beds, and enhances the patient experience.

Joe Cain

Leader of Acute Care Informatics, Philips APAC

Transforming Care for High-Risk Surgical Patients

Traditionally, patients undergoing spinal surgery for scoliosis require intensive post-operative monitoring in ICUs or high-dependency units (HDUs). This places considerable strain on hospital resources and limits the number of elective procedures that can proceed—especially when ICU beds are unavailable.

The HIVE model, implemented in 2020 at Royal Perth Hospital, offered a transformative alternative: equipping general ward beds with Philips MX400 bedside monitors, high-resolution medical-grade cameras, and a fully integrated clinical command centre powered by the Philips IntelliSpace Critical Care and Anaesthesia (ICCA) and eCareManager platforms [2]. These technologies enabled 24/7 remote surveillance of patients by a dedicated clinical team, creating an additional safety net while allowing recovery in a less intensive and more familiar ward environment.

The results were compelling: of the 288 patients assessed in the study, those managed post-HIVE implementation spent nearly 17 fewer hours in ICU on average than those in the traditional care group. Importantly, there was no increase in hospital length of stay, emergency readmissions, or hospital-acquired complications—reaffirming the safety and reliability of continuous remote monitoring in surgical wards.

Command Cente image2

Partnership-Driven Innovation

The success of the HIVE program is a testament to the power of collaboration between healthcare providers and technology partners. Philips provided not just equipment, but a holistic solution, integrating bedside, audiovisual, and digital platforms into a unified monitoring system that streamlined workflow and improved decision-making.

The remote monitoring centre was equipped to live-stream vital signs, apply machine learning algorithms continuously assessing patient risk, and maintain virtual communication with bedside teams. Using artificial intelligence and continuous data analysis, early warning signs could be detected and escalated faster, improving the chances of timely intervention.

The key to HIVE’s success has been the seamless integration of people, process, and technology. Philips’ technology was instrumental in enabling this new model of care, and our findings show the potential to deliver better outcomes at lower costs.

Dr Kevin Trentino

Lead author of the study and Manager of Research and Evaluation with Community & Virtual Care at East Metropolitan Health Service

Easing Pressure on Critical Care

Australia’s ICU resources are limited and expensive. With ICU care costing an estimated AU$2.1 billion annually [3], the need for smart, sustainable solutions is growing. By allowing suitable patients to recover safely on general wards, the HIVE model frees up ICU beds for those who need them most, while reducing cancellations of elective surgery due to bed shortages.

Moreover, the cost-effectiveness analysis in the study found that the HIVE model was not only more effective, with the time a patient spends in ICU reduced by 17 hours, but also less expensive, with a cost saving of $2,682 AUD per patient [4], a rare and powerful combination in healthcare transformation. Most Importantly the study showed no increase of complications or readmissions.

The study’s findings align with global trends highlighting the value of remote monitoring in hospitals. Philips’ recent work with health systems across North America, the Middle East and Japan has shown similar gains in early detection, workflow efficiency, and reduced clinician workload.

The Future of Virtual Care

As Australia continues to evolve its digital health infrastructure, the HIVE program offers a blueprint for extending high-acuity care beyond traditional boundaries. With Philips’ support, Royal Perth Hospital has demonstrated that hospitals can harness remote technologies to deliver safer, smarter, and more patient-centric care—even in resource-constrained environments.

This partnership with Royal Perth Hospital shows what’s possible when innovation meets clinical excellence. Philips remains committed to supporting hospitals in their digital transformation journeys, ensuring that every patient, in every ward, receives the highest standard of care.

Joe Cain

Leader of Acute Care Informatics, Philips APAC

To read the study, click here.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Click here to read moreClick here to read less

Topics

Contacts

hw headshot

Hayley Willis

Communications and Brand Manager

Philips Australia & New Zealand 

You are about to visit a Philips global content page

Continue

Media assets

Share on social media

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

You are entering a Philips Healthcare Australia website
Please select the checkbox

The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).

By clicking "Continue" you are indicating that you are one of the intended audience. Click cancel to be redirected to the Philips website.